This paper examines how electronic informed consent (eConsent) can streamline global clinical trials. Traditional paper-based consent creates delays, compliance risks, and inconsistent patient understanding. eConsent offers interactive, multimedia-supported explanations, standardized workflows, and real-time updates across regions. It enhances comprehension, increases patient engagement, and reduces site burden. While challenges include varying regulations and infrastructure, adopting eConsent globally enables scalable, patient-friendly trials, strengthens compliance, and accelerates study start-up.

Join for free to read